Research summary from #DESTINYBreast09 presented at #AM25 now live: Trastuzumab deruxtecan and pertuzumab can delay cancer growth for people with HER2+ advanced or metastatic #BreastCancer.

Learn more: brnw.ch/21wT5D9
#BCSM